Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Shares Purchased by Samalin Investment Counsel LLC

Samalin Investment Counsel LLC increased its holdings in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 11.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 14,257 shares of the real estate investment trust’s stock after buying an additional 1,437 shares during the period. Samalin Investment Counsel LLC’s holdings in Sabra Health Care REIT were worth $247,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in SBRA. Geode Capital Management LLC increased its position in shares of Sabra Health Care REIT by 1.7% during the third quarter. Geode Capital Management LLC now owns 6,294,798 shares of the real estate investment trust’s stock worth $117,165,000 after acquiring an additional 104,533 shares during the period. JPMorgan Chase & Co. grew its stake in Sabra Health Care REIT by 222.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust’s stock worth $183,996,000 after purchasing an additional 6,819,919 shares in the last quarter. Vestcor Inc increased its holdings in Sabra Health Care REIT by 62.5% during the 3rd quarter. Vestcor Inc now owns 207,918 shares of the real estate investment trust’s stock worth $3,869,000 after purchasing an additional 79,956 shares during the period. Barclays PLC raised its position in Sabra Health Care REIT by 56.1% in the 3rd quarter. Barclays PLC now owns 678,397 shares of the real estate investment trust’s stock valued at $12,624,000 after purchasing an additional 243,895 shares in the last quarter. Finally, Franklin Resources Inc. raised its position in Sabra Health Care REIT by 12.3% in the 3rd quarter. Franklin Resources Inc. now owns 524,917 shares of the real estate investment trust’s stock valued at $9,543,000 after purchasing an additional 57,551 shares in the last quarter. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Sabra Health Care REIT Trading Down 0.4 %

NASDAQ SBRA opened at $17.26 on Monday. The firm’s fifty day moving average price is $16.79 and its 200 day moving average price is $17.68. Sabra Health Care REIT, Inc. has a 12 month low of $13.31 and a 12 month high of $20.03. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16. The company has a market capitalization of $4.11 billion, a price-to-earnings ratio of 32.57, a price-to-earnings-growth ratio of 1.97 and a beta of 1.27.

Sabra Health Care REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.36. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. The company had revenue of $182.35 million for the quarter, compared to analyst estimates of $178.01 million. On average, sell-side analysts expect that Sabra Health Care REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Friday, February 14th were given a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 6.95%. The ex-dividend date of this dividend was Friday, February 14th. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 226.42%.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the company. JMP Securities raised Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective for the company in a research report on Tuesday, January 7th. Truist Financial increased their price objective on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “hold” rating in a research report on Tuesday, March 18th. Mizuho reaffirmed a “neutral” rating and set a $20.00 price objective on shares of Sabra Health Care REIT in a research report on Thursday, December 5th. Finally, Citizens Jmp raised Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 7th. Three research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, Sabra Health Care REIT has a consensus rating of “Moderate Buy” and a consensus target price of $19.33.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.